## Distinguishing SLE from Drug-Induced Lupus ### Key Serological Differences **Key Point:** Anti-dsDNA (double-stranded DNA) antibodies are highly specific for SLE and are virtually absent in drug-induced lupus (DIL), making them the single best discriminator. | Feature | SLE | Drug-Induced Lupus | |---------|-----|-------------------| | **Anti-dsDNA** | Present (70–80%) | Absent (rare) | | **Anti-histone** | Present (60–70%) | Present (95%+) | | **ANA pattern** | Variable (speckled, homogeneous) | Homogeneous (typical) | | **Anti-Ro/SSA** | Present (40–60%) | Absent | | **Complement (C3/C4)** | Low (active disease) | Normal | ### Clinical Pearl **High-Yield:** Anti-dsDNA positivity correlates with lupus nephritis and is part of the SLE classification criteria. Its presence in a patient with ANA-positive lupus-like illness strongly favors idiopathic SLE over DIL. ### Why Anti-dsDNA is Superior Anti-histone antibodies are present in both SLE and DIL (in fact, more common in DIL), so they do not discriminate. Anti-Ro/SSA, while specific for SLE, is absent in 40–50% of SLE patients. ANA pattern alone is non-specific. Only anti-dsDNA is both highly specific for SLE and essentially absent in DIL. **Mnemonic:** **DSDNA = Definitely SLE, Definitely Not DIL** ### Clinical Context Drug-induced lupus typically remits within weeks to months of drug withdrawal and does not cause lupus nephritis or CNS involvement; anti-dsDNA negativity supports this diagnosis when DIL is suspected [cite:Harrison 21e Ch 319].
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.